OSE Immunotherapeutics SA (0RAD) Financial Statements
OSE Immunotherapeutics SA Financial Overview
OSE Immunotherapeutics SA's market cap is currently $45.93M. The company's EPS TTM is $-1.69; its P/E ratio is -1.16; OSE Immunotherapeutics SA has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.62M | $ 69.88M | $ 2.23M | $ 18.30M | $ 26.31M |
| Gross Profit | $ 2.62M | $ 69.88M | $ 2.23M | $ 18.30M | $ 26.31M |
| Operating Income | $ -48.06M | $ 43.73M | $ -22.99M | $ -18.48M | $ -16.63M |
| EBITDA | $ -44.81M | $ 41.14M | $ -17.50M | $ -13.11M | $ -13.72M |
| Net Income | $ -37.70M | $ 37.45M | $ -23.00M | $ -17.76M | $ -16.85M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 22.65M | $ 16.75M | $ 18.67M | $ 25.62M | $ 33.58M |
| Total Assets | $ 78.44M | $ 123.96M | $ 82.05M | $ 91.67M | $ 101.52M |
| Total Debt | $ 35.38M | $ 46.13M | $ 45.80M | $ 44.79M | $ 37.13M |
| Net Debt | $ 17.82M | $ 29.39M | $ 27.13M | $ 19.17M | $ 3.55M |
| Total Liabilities | $ 51.10M | $ 60.15M | $ 59.08M | $ 59.12M | $ 53.99M |
| Stockholders' Equity | $ 27.34M | $ 63.81M | $ 22.82M | $ 32.55M | $ 47.89M |
| Cash Flow | |||||
| Free Cash Flow | $ -34.13M | $ 48.36M | $ -20.00M | $ -18.53M | $ -10.39M |
| Operating Cash Flow | $ -34.03M | $ 48.44M | $ -19.76M | $ -18.25M | $ -9.92M |
| Investing Cash Flow | $ 41.35M | $ -46.91M | $ -507.00K | $ 26.00K | $ -827.00K |
| Financing Cash Flow | $ -6.51M | $ -3.46M | $ 13.32M | $ 10.27M | $ 14.96M |
Currency in EUR
